QDEL QuidelOrtho Corporation

  1. Stocks
  2. Healthcare
  3. NASDAQ: QDEL

Price (delayed)

$16.05

Market cap

$1.09B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$17.8

Enterprise value

$3.8B

?
Relative Growth: Rel. Growth: 5
Relative Strength: Rel. Strength: 32
Relative Valuation: Rel. Valuation: 36
Relative Profitability: Rel. Profitability: 15

With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help ...

Highlights
QDEL's quick ratio is up by 33% YoY but it is down by 15% from the previous quarter
The equity has contracted by 38% YoY and by 3.6% from the previous quarter
QuidelOrtho's gross profit has decreased by 8% YoY and by 6% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: http://www.quidel.com
Peers: BDX TMO OSUR DHR

Key stats

What are the main financial stats of QDEL

QDEL stock price

How has the QuidelOrtho stock price performed over time
Intraday
-3.2%
1 week
-7.65%
1 month
31.45%
1 year
-39.04%
YTD
-43.8%
QTD
-8.36%

Financial performance

How have QuidelOrtho's revenue and profit performed over time
Revenue
$2.66B
Gross profit
$1.19B
Operating income
-$983.6M
Net income
-$1.21B
Gross margin
45%
Net margin
-45.6%
QDEL's net margin is down by 10% from the previous quarter
QuidelOrtho's operating margin has decreased by 10% from the previous quarter
QuidelOrtho's gross profit has decreased by 8% YoY and by 6% QoQ
QuidelOrtho's operating income has decreased by 7% from the previous quarter

Price vs fundamentals

How does QDEL's price correlate with its fundamentals

Growth

What is QuidelOrtho's growth rate over time

Valuation

What is QuidelOrtho stock price valuation
QDEL P/E details
P/E
N/A
P/B
0.59
P/S
0.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.43
The company's EPS fell by 7% QoQ
The stock's price to book (P/B) is 51% less than its 5-year quarterly average of 1.2 and 26% less than its last 4 quarters average of 0.8
The equity has contracted by 38% YoY and by 3.6% from the previous quarter
QDEL's P/S is 73% below its 5-year quarterly average of 1.5 and 32% below its last 4 quarters average of 0.6
QDEL's revenue is down by 3.9% year-on-year and by 2.7% since the previous quarter

Efficiency

How efficient is QuidelOrtho business performance
QuidelOrtho's return on equity has decreased by 21% QoQ
QDEL's return on assets is down by 11% since the previous quarter
The company's return on sales fell by 9% QoQ
QDEL's return on invested capital is down by 5% since the previous quarter

Dividends

What is QDEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for QDEL.

Financial health

How did QuidelOrtho financials performed over time
QDEL's total assets is 49% greater than its total liabilities
QDEL's quick ratio is up by 33% YoY but it is down by 15% from the previous quarter
The current ratio has increased by 19% YoY but it has decreased by 4.7% from the previous quarter
QDEL's debt is 54% more than its equity
The debt to equity has surged by 73% year-on-year and by 5% since the previous quarter
The equity has contracted by 38% YoY and by 3.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.